{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T01:35:49Z","timestamp":1783042549721,"version":"3.54.6"},"reference-count":32,"publisher":"Elsevier BV","issue":"37","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.vaccine.2010.06.119","type":"journal-article","created":{"date-parts":[[2010,7,16]],"date-time":"2010-07-16T09:26:29Z","timestamp":1279272389000},"page":"5967-5972","source":"Crossref","is-referenced-by-count":9,"title":["Effect of human serum on de-N-acetyl sialic acid epitope expression and antibody activity against N. meningitidis group B"],"prefix":"10.1016","volume":"28","author":[{"given":"Becca A.","family":"Flitter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica Y.","family":"Ing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory R.","family":"Moe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2010.06.119_bib1","series-title":"Vaccines","first-page":"959","article-title":"Meningococcal vaccines","author":"Granoff","year":"2004"},{"key":"10.1016\/j.vaccine.2010.06.119_bib2","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/S0140-6736(02)08416-7","article-title":"Development of vaccines against meningococcal disease","volume":"359","author":"Jodar","year":"2002","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.vaccine.2010.06.119_bib3","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/infdis\/171.6.1481","article-title":"Antibodies to polysialic acid and its N-propyl derivative: binding properties and interaction with human embryonal brain glycopeptides","volume":"171","author":"Hayrinen","year":"1995","journal-title":"J Infect Dis"},{"issue":"8346","key":"10.1016\/j.vaccine.2010.06.119_bib4","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(83)90340-9","article-title":"Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis","volume":"2","author":"Finne","year":"1983","journal-title":"Lancet"},{"issue":"9\u201310","key":"10.1016\/j.vaccine.2010.06.119_bib5","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.vaccine.2003.10.005","article-title":"Clinical evaluation of a group B meningococcal N-propionylated polysaccharide conjugate vaccine in adult, male volunteers","volume":"22","author":"Bruge","year":"2004","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2010.06.119_bib6","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.4049\/jimmunol.137.5.1708","article-title":"Induction of meningococcal group B polysaccharide-specific IgG antibodies in mice by using an N-propionylated B polysaccharide-tetanus toxoid conjugate vaccine","volume":"137","author":"Jennings","year":"1986","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2010.06.119_bib7","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1172\/JCI109383","article-title":"Complex of meningococcal group B polysaccharide and type 2 outer membrane protein immunogenic in man","volume":"63","author":"Zollinger","year":"1979","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.vaccine.2010.06.119_bib8","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1073\/pnas.0807207106","article-title":"Sialylated multivalent antigens engage CD22 in trans and inhibit B cell activation","volume":"106","author":"Courtney","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"10.1016\/j.vaccine.2010.06.119_bib9","doi-asserted-by":"crossref","first-page":"6610","DOI":"10.4049\/jimmunol.0803677","article-title":"Vaccines containing de-N-acetyl sialic acid elicit antibodies protective against Neisseria meningitidis groups B and C","volume":"182","author":"Moe","year":"2009","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2010.06.119_bib10","doi-asserted-by":"crossref","first-page":"501","DOI":"10.4049\/jimmunol.177.1.501","article-title":"The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance","volume":"177","author":"Madico","year":"2006","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2010.06.119_bib11","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1128\/IAI.01191-08","article-title":"Binding of complement factor H (fH) to Neisseria meningitidis is specific for human fH and inhibits complement activation by rat and rabbit sera","volume":"77","author":"Granoff","year":"2009","journal-title":"Infect Immun"},{"issue":"20","key":"10.1016\/j.vaccine.2010.06.119_bib12","doi-asserted-by":"crossref","first-page":"11751","DOI":"10.1073\/pnas.95.20.11751","article-title":"A mutation in human CMP-sialic acid hydroxylase occurred after the Homo-Pan divergence","volume":"95","author":"Chou","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"10.1016\/j.vaccine.2010.06.119_bib13","doi-asserted-by":"crossref","first-page":"5028","DOI":"10.4049\/jimmunol.160.10.5028","article-title":"Bactericidal monoclonal antibodies that define unique meningococcal B polysaccharide epitopes that do not cross-react with human polysialic acid","volume":"160","author":"Granoff","year":"1998","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2010.06.119_bib14","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1128\/IAI.73.4.2123-2128.2005","article-title":"Epitopes recognized by a nonautoreactive murine anti-N-propionyl meningococcal group B polysaccharide monoclonal antibody","volume":"73","author":"Moe","year":"2005","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.vaccine.2010.06.119_bib15","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.molimm.2005.07.033","article-title":"Molecular analysis of anti-N-propionyl Neisseria meningitidis group B polysaccharide monoclonal antibodies","volume":"43","author":"Moe","year":"2006","journal-title":"Mol Immunol"},{"key":"10.1016\/j.vaccine.2010.06.119_bib16","unstructured":"Seid R, inventor Chiron S.r.l., assignee. Neisseria meningitidis serogroup B Glycoconjugates. US patent no. 6,638,513; 2003."},{"key":"10.1016\/j.vaccine.2010.06.119_bib17","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3109\/08830180109043034","article-title":"Molecular mimetics of Neisseria meningitidis serogroup B polysaccharide","volume":"20","author":"Moe","year":"2001","journal-title":"Intern Rev Immunol"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2010.06.119_bib18","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1574-695X.1999.tb01392.x","article-title":"Molecular mimetics of polysaccharide epitopes as vaccine candidates for prevention of Neisseria meningitidis serogroup B disease","volume":"26","author":"Moe","year":"1999","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"11","key":"10.1016\/j.vaccine.2010.06.119_bib19","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1128\/IAI.59.11.4097-4102.1991","article-title":"Insertion of Tn916 in Neisseria meningitidis resulting in loss of group B capsular polysaccharide","volume":"59","author":"Stephens","year":"1991","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2010.06.119_bib20","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1128\/CVI.13.4.486-491.2006","article-title":"The VR2 epitope on the PorA P1.7-2,4 protein is the major target for the immune response elicited by the strain-specific group B meningococcal vaccine MeNZB","volume":"13","author":"Martin","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2010.06.119_bib21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1590\/S1517-83822003000100007","article-title":"Polysaccharide production in batch process of Neisseria meningitidis serogroup C comparing Frantz, modified Frantz and Catlin 6 cultivation media","volume":"34","author":"Fossa da Paz","year":"2003","journal-title":"Braz J Micro"},{"issue":"6","key":"10.1016\/j.vaccine.2010.06.119_bib22","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1084\/jem.129.6.1307","article-title":"Human immunity to the meningococcus. I. The role of humoral antibodies","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J Exp Med"},{"issue":"20\u201321","key":"10.1016\/j.vaccine.2010.06.119_bib23","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1016\/S0264-410X(99)00049-3","article-title":"The infant rat model adapted to evaluate human sera for protective immunity to group B meningococci","volume":"17","author":"Toropainen","year":"1999","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2010.06.119_bib24","doi-asserted-by":"crossref","first-page":"5664","DOI":"10.1128\/IAI.67.11.5664-5675.1999","article-title":"Differences in surface expression of NspA among Neisseria meningitidis group B strains","volume":"67","author":"Moe","year":"1999","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2010.06.119_bib25","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1086\/379375","article-title":"Antibody to genome-derived neisserial antigen 2132, a Neisseria meningitidis candidate vaccine, confers protection against bacteremia in the absence of complement-mediated bactericidal activity","volume":"188","author":"Welsch","year":"2003","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2010.06.119_bib26","doi-asserted-by":"crossref","first-page":"6021","DOI":"10.1128\/IAI.70.11.6021-6031.2002","article-title":"Sequential immunization with vesicles prepared from heterologous Neisseria meningitidis strains elicits broadly protective serum antibodies to group B strains","volume":"70","author":"Moe","year":"2002","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2010.06.119_bib27","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1128\/IAI.69.6.3762-3771.2001","article-title":"Functional activity of anti-Neisserial surface protein A monoclonal antibodies against strains of Neisseria meningitidis serogroup B","volume":"69","author":"Moe","year":"2001","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2010.06.119_bib28","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1128\/CVI.00007-09","article-title":"Ex vivo model of meningococcal bacteremia using human blood for measuring vaccine-induced serum passive protective activity","volume":"16","author":"Plested","year":"2009","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2010.06.119_bib29","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1128\/IAI.55.1.174-180.1987","article-title":"Sialic acid of group B Neisseria meningitidis regulates alternative complement pathway activation","volume":"55","author":"Jarvis","year":"1987","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.vaccine.2010.06.119_bib30","doi-asserted-by":"crossref","first-page":"5939","DOI":"10.1128\/IAI.66.12.5939-5947.1998","article-title":"The (alpha2\u21928)-linked polysialic acid capsule and lipooligosaccharide structure both contribute to the ability of serogroup B Neisseria meningitidis to resist the bactericidal activity of normal human serum","volume":"66","author":"Kahler","year":"1998","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2010.06.119_bib31","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1096\/fasebj.11.4.9068613","article-title":"Sialic acids as ligands in recognition phenomena","volume":"11","author":"Varki","year":"1997","journal-title":"FASEB J"},{"issue":"22","key":"10.1016\/j.vaccine.2010.06.119_bib32","doi-asserted-by":"crossref","first-page":"13091","DOI":"10.1016\/S0021-9258(19)38271-7","article-title":"Biosynthesis and turnover of O-acetyl and N-acetyl groups in the gangliosides of human melanoma cells","volume":"265","author":"Manzi","year":"1990","journal-title":"J Biol Chem"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10009618?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10009618?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T04:14:06Z","timestamp":1685679246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10009618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":32,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0264410X10009618"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.06.119","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}